Cellcolabs Clinical sponsors and conducts clinical trials using its proprietary Mesenchymal Stem Cell therapies to treat osteoarthritis and other musculoskeletal conditions. Our research also explores the potential of these therapies in the prevention of cardiovascular disease and other age-related conditions, advancing regenerative medicine through rigorous clinical science.